- Trius Therapeutics $TSRX is not a company I follow with a complete page on BiotechDueDiligence, nor do I own the stock.
- I think it is an interesting company, so I'll share my webcast notes below (and check out @JNapodano on Twitter for the most complete coverage of TSRX)